SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 261 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $94,758 | -47.0% | 3,437 | -42.2% | 0.02% | -61.5% |
| Q2 2023 | $178,797 | -16.7% | 5,948 | +0.4% | 0.05% | -24.6% |
| Q1 2023 | $214,699 | -4.8% | 5,926 | -6.2% | 0.07% | -8.0% |
| Q4 2022 | $225,470 | +77.5% | 6,321 | +68.5% | 0.08% | +19.0% |
| Q3 2022 | $127,000 | -17.5% | 3,752 | -29.6% | 0.06% | -33.7% |
| Q2 2022 | $154,000 | +40.0% | 5,327 | +56.9% | 0.10% | +72.7% |
| Q1 2022 | $110,000 | +77.4% | 3,396 | +59.1% | 0.06% | +89.7% |
| Q4 2021 | $62,000 | +5.1% | 2,135 | -2.9% | 0.03% | -23.7% |
| Q3 2021 | $59,000 | +5.4% | 2,198 | +20.0% | 0.04% | +8.6% |
| Q2 2021 | $56,000 | – | 1,832 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |